Aptose Biosciences Inc (APTO)
NASDAQ
Quarter End | 3 2022 | 6 2022 | 9 2022 | 3 2023 | 6 2023 | 9 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 72.6M | 64.81M | 57.05M | 39.33M | 26.58M | 20.88M | 12.8M | 10.95M |
流動資産合計 | 71.87M | 64.19M | 56.58M | 37.93M | 25.26M | 19.67M | 11.82M | 10.16M |
現金および同等物 | 36.99M | 40.03M | 27.99M | 22.76M | 8.4M | 15.72M | 7.35M | 8.33M |
非流動資産合計 | 574k | 562k | 502k | 366k | 380k | 340k | 250k | 68k |
負債合計 | 7.32M | 9.32M | 10.23M | 13.34M | 12.79M | 13.1M | 12.66M | 13.13M |
流動負債合計 | 7.31M | 9.31M | 10.23M | 12.42M | 11.97M | 12.38M | 12.14M | 12.71M |
非流動負債合計 | 20k | 6k | 2k | 1.84M | 1.63M | 720k | 1.04M | 414k |
普通株 | 437.41M | 437.44M | 437.47M | 437.95M | 439.1M | 443.94M | 450.49M | 452.29M |
留保所得 | -433.99M | -444.55M | -454.33M | -478.01M | -492.14M | -503.58M | -525.18M | -532.43M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 11.61M | 11.97M | 16.87M | 100.48M | 126.26M | 82.53M | 51.03M | 12.99M |
流動資産合計 | 11.33M | 11.83M | 16.49M | 98.77M | 125.08M | 81.74M | 49.52M | 11.89M |
現金および同等物 | 10.66M | 10.63M | 15.3M | 79.84M | 117.39M | 39.11M | 36.97M | 9.25M |
非流動資産合計 | 9.84M | 10.2M | 14.08M | 93.93M | 118.92M | 74.24M | 37.74M | -2.9M |
負債合計 | 1.77M | 1.77M | 2.79M | 6.55M | 7.35M | 8.29M | 13.29M | 15.89M |
流動負債合計 | 1.77M | 1.77M | 2.79M | 5.54M | 6.81M | 8.17M | 12.28M | 15.27M |
非流動負債合計 | 0 | 0 | 0 | 2.02M | 1.07M | 230k | 2M | 621k |
総資本 | 9.84M | 10.2M | 14.08M | 93.93M | 118.92M | 74.24M | 37.74M | -2.9M |
普通株 | 239.11M | 238.38M | 261.07M | 365.49M | 429.52M | 437.39M | 437.52M | 444.81M |
留保所得 | -251.54M | -246.79M | -279.95M | -301.92M | -357.15M | -422.51M | -464.33M | -515.54M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約